Huma Secures Over $80M in Series D Funding to Enhance Global Healthcare AI Solutions
Huma specializes in transforming care delivery and research through digital solutions.
Company Name: Huma
Location: London, UK
Sector: Healthcare, Artificial Intelligence
Funding Details: Raised over $80M in Series D funding. The investment round included notable backers such as AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, Leaps by Bayer, among others.
Purpose of Investment: To expand operations and extend business reach globally.
Leadership: Led by Founder and CEO Dan Vahdat.
Product and Innovations: Huma is a global healthcare AI company that develops modular platforms to accelerate the adoption of digital healthcare solutions. The company supports over 3,000 hospitals and clinics worldwide, with its platforms used by millions. Alongside the funding, Huma is launching the Huma Cloud Platform, a comprehensive technology ecosystem designed to bolster its digital health initiatives and enable others to efficiently launch and scale their projects. This platform offers a range of features including no-code configuration of disease management tools, a library of pre-built modules, device connectivity, cloud-agnostic hosting, APIs, and the ability to host and deploy AI algorithms.
About Company: Huma specializes in transforming care delivery and research through digital solutions. It has played a pivotal role in national healthcare projects across various countries, including the US, UK, Germany, Greece, and Saudi Arabia, and collaborates extensively with pharmaceutical companies. With total funding now over $300 million, Huma is poised to further innovate and expand its impact in the healthcare sector, continuing to advance digital-first care and research globally.